Factors determining cellular mechanisms of resistance to antimitotic drugs

Drug Resistance Updates

Volumn 4, Issue 1, 2001, Pages 3-8

  Cabral, Fernando ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIMITOTIC AGENT; COLCHICINE; PACLITAXEL; TAXANE DERIVATIVE; VINBLASTINE;

ANALYTIC METHOD; CANCER CHEMOTHERAPY; CELL CULTURE; CYTOTOXICITY; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR RESISTANCE;

EID: 0035060238     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2000.0172     Document Type: Review

References (34)

1. The relationship between tumor mass and resistance to chemotherapy
2. Paclitaxel (Taxol): Mechanisms of resistance
3. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
4. Isolation of Chinese hamster ovary cell mutants requiring the continuous presence of taxol for cell division
5. Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly
6. A mechanism of cellular resistance to drugs that interfere with microtubule assembly
7. Characterization of a taxol-resistant human small-cell lung cancer cell line
8. Taxol-dependent mutants of Chinese hamster ovary cells with alterations in α- and β-tubulin
9. Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization
10. A phosphoglycoprotein associated with taxol resistance in J774.2 cells
11. A multidrug resistance murine cell line is partially dependent on taxol for growth and has an increased tubulin content
12. Structure and utilization of tubulin isotypes
13. Multiple forms of tubulin: Different gene products and covalent modifications
14. Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance
15. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes
16. Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833
17. IVa-tubulin in human prostate carcinoma cells as a result of estramustine resistance
18. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol)
19. Overexpression of class I, II, or IVb β-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel
20. The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer
21. Current options in treatment of anthracycline-resistant breast cancer
22. Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer
23. Elimination of permeability mutants from selections for drug resistance in mammalian cells
24. Expression and function of β-tubulin isotypes in Chinese hamster ovary cells
25. Nucleotide sequences of three different isoforms of beta-tubulin cDNA from Chinese hamster ovary cells
26. Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly
27. Mechanisms of cellular resistance to drugs that target microtubules
28. Differential binding of methyl benzimidazole-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans
29. Isolation and characterization of mutations in the β-tubulin gene of Saccharomyces cerevisiae
30. Characterization of microtubule assembly in porcine brain extracts by viscometry
31. A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells
32. Significance of multiple mutations in cancer
33. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin
34. β-Tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance